164 related articles for article (PubMed ID: 26583450)
1. Correlates of Skin and Soft Tissue Infections in Injection Drug Users in a Syringe-Exchange Program in Malmö, Sweden.
Dahlman D; Håkansson A; Björkman P; Blomé MA; Kral AH
Subst Use Misuse; 2015; 50(12):1529-35. PubMed ID: 26583450
[TBL] [Abstract][Full Text] [Related]
2. Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: A community-based observational study.
Dahlman D; Håkansson A; Kral AH; Wenger L; Ball EL; Novak SP
Subst Abus; 2017; 38(1):105-112. PubMed ID: 27897966
[TBL] [Abstract][Full Text] [Related]
3. Predictors of skin and soft tissue infections among sample of rural residents who inject drugs.
Baltes A; Akhtar W; Birstler J; Olson-Streed H; Eagen K; Seal D; Westergaard R; Brown R
Harm Reduct J; 2020 Dec; 17(1):96. PubMed ID: 33267848
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
Hakansson A; Medvedeo A; Andersson M; Berglund M
Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with chronic pain and non-medical opioid use among people who inject drugs.
Bicket MC; Park JN; Torrie A; Allen ST; Weir BW; Sherman SG
Addict Behav; 2020 Mar; 102():106172. PubMed ID: 31704433
[TBL] [Abstract][Full Text] [Related]
6. A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States.
Ozga JE; Syvertsen JL; Zweifler JA; Pollini RA
Health Soc Care Community; 2022 Sep; 30(5):1798-1808. PubMed ID: 34469034
[TBL] [Abstract][Full Text] [Related]
7. Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina.
Figgatt MC; Salazar ZR; Vincent L; Carden-Glenn D; Link K; Kestner L; Yates T; Schranz A; Joniak-Grant E; Dasgupta N
Harm Reduct J; 2021 Jul; 18(1):80. PubMed ID: 34330297
[TBL] [Abstract][Full Text] [Related]
8. Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs.
Des Jarlais DC; Braine N; Friedmann P
AIDS Behav; 2007 Nov; 11(6 Suppl):78-84. PubMed ID: 17447132
[TBL] [Abstract][Full Text] [Related]
9. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.
Bazazi AR; Yokell M; Fu JJ; Rich JD; Zaller ND
J Addict Med; 2011 Sep; 5(3):175-80. PubMed ID: 21844833
[TBL] [Abstract][Full Text] [Related]
10. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
Yen YF; Yen MY; Su LW; Li LH; Chuang P; Jiang XR; Deng CY
BMC Public Health; 2012 Dec; 12():1066. PubMed ID: 23227904
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.
Lloyd-Smith E; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
BMC Public Health; 2008 Dec; 8():405. PubMed ID: 19068133
[TBL] [Abstract][Full Text] [Related]
12. Correlates of injecting in an HIV incidence hotspot among substance users in Tijuana, Mexico.
Kori N; Roth AM; Lozada R; Vera A; Brouwer KC
Int J Drug Policy; 2014 May; 25(3):525-32. PubMed ID: 24418632
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study.
Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J;
Drug Alcohol Depend; 2022 Aug; 237():109543. PubMed ID: 35772249
[TBL] [Abstract][Full Text] [Related]
14. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
[TBL] [Abstract][Full Text] [Related]
15. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
Pizzicato LN; Johnson CC; Viner KM
Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
[No Abstract] [Full Text] [Related]
16. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
[TBL] [Abstract][Full Text] [Related]
17. [Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan].
Zhou Y; Luo W; Cao XB; Zhang B; Wu ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):648-52. PubMed ID: 27188355
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.
Phillips KT; Anderson BJ; Herman DS; Liebschutz JM; Stein MD
J Addict Med; 2017; 11(6):461-467. PubMed ID: 28767536
[TBL] [Abstract][Full Text] [Related]
19. Cross-border activities and association with current methamphetamine use among Chinese injection drug users (IDUs) in a China-Myanmar border region.
Li L; Assanangkornchai S; Duo L; McNeil E; Li J
Drug Alcohol Depend; 2014 May; 138():48-53. PubMed ID: 24629780
[TBL] [Abstract][Full Text] [Related]
20. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
